Tineka (Tina) Quinton focuses her practice on obtaining and evaluating intellectual property protection and in providing strategic counsel to her clients. She currently represents clients in the areas of biotechnology, bioinformatics and pharmaceuticals, with special emphasis in molecular biology, immunology, viral vectors, gene therapy, antibodies and RNA-based therapeutics. In addition to the preparation and prosecution of U.S. and foreign patent applications, a substantial part of Tina’s practice is focused on the preparation of patentability, infringement, validity and freedom-to-practice opinions.
Prior to becoming a patent attorney in 2003, Tina obtained extensive scientific expertise during her career as a research scientist while working at several biotechnology companies and non-profit institutions including Targeted Genetics, ZymoGenetics, and the Fred Hutchinson Cancer Research Center. As a published research scientist and patent holder, Tina is well versed in her client’s challenges both in the laboratory and in effectively handling intellectual property matters.
Education
- J.D., with honors, University of Washington School of Law, 2003
- M.S. Molecular and Cellular Biology, University of Washington, 1993
- B.S. Biology/Chemistry, Gordon College, 1984
Professional Experience
- Christensen O’Connor Johnson KindnessPLLC, Seattle WA, 2001 to present
Technical Experience
- Research Scientist, ZymoGenetics, 1999 to 2001
- Research Scientist, PanLabs, Inc., 1998 to 1999
- Research Scientist, Targeted Genetics Corporation, 1992 to 1998
- Graduate Student, Fred Hutchinson Cancer Research Center, 1989 to 1992
- Research Associate, Dana Farber Cancer Research Institute, MA, 1987-1989
Bar & Court Admissions
- Washington State Bar
- United States Patent and Trademark Office
Professional Affiliations
- King County Bar Association
- Washington State Patent Law Association
- Intellectual Property Owners Association
- Licensing Executives Society
Patents (obtained as an inventor)
U.S. Patent No. 6,541,258, “Adeno Associated Virus (AAV) Split-Packaging Genes and Cell Lines Comprising Such Genes for use in the Production of Recombinant AAV Vectors,” Allen, J., Stephan, A., Quinton, T., Lupton, S.
Publications
Li, L., Quinton, T., Miles, S., Breeden, L., “Genetic Interactions Between Mediator and the late G1-specific Transcription Factor Swi6 in Saccharomyces cerevisiae,” Genetics, Vol. 171(2):477-88 (2005)
Whitmore, T., Holloway, J., Lofton-Day, C., Maurer, M., Chen, L., Quinton, T., Vincent, J., Schere, S., Lok, S., “Human Secretin (SCT): Gene structure, Chromosome Location, and Distribution of mRNA,” Cytogenetics and Cell Genetics, Vol. 90:47-52 (2000)
Quinton, T., et al., “Rapid Construction of Knockout Vectors by Homologous Recombination in E. Coli,” Keystone Symposium (2000)
Quinton, T., et al., “Molecular Events Following AAV Transduction,” Keystone Symposium (1997)
Guthrie, P., Quinton, T., Moran, L., Slatko, B., Kucera, R., Benner, J., Wilson, G., Brooks, J., “Cloning Expression and Sequence Analysis of the Sph1 Restriction-Modification System,” Gene, Vol. 180(1-2):107-112 (1996)
Levine, K., Steiner, B., Johnson, K., Aronoff, R., Quinton, T., Linial, M., “Unusual Features of Integrated cNDAs Generated by Infection with Genome-Free Retroviruses,” Molecular and Cellular Biology, Vol. 10(5) 5:1891-1990 (1990)